Skip to main content

Day: March 6, 2024

Man Group PLC : Form 8.3 – Spirent Communications plc

Written by Customer Service on . Posted in Public Companies.

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: Man Group PLC(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.  (c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree Spirent Communications plc(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:  (e)   Date position held/dealing undertaken:        For an opening...

Continue reading

INNOVATE Corp. Announces Rights Offering Pricing

Written by Customer Service on . Posted in Dividend Reports And Estimates.

NEW YORK, March 06, 2024 (GLOBE NEWSWIRE) — INNOVATE Corp. (“INNOVATE” or the “Company”) (NYSE: VATE), a diversified holding company, announced today that it has approved the pricing for its previously announced rights offering. The Company will distribute to each holder of the Company’s common stock as of March 6, 2024 (the “rights offering record date”), one transferable subscription right to purchase 0.2858 shares of the Company’s common stock at a price of $0.70 per whole share. Holders of the Company’s existing preferred stock and convertible notes that are entitled to participate in dividend distributions to holders of the Company’s common stock will also be entitled to participate in the rights offering. The offering will expire at 5:00 PM Eastern Time on March 25, 2024, unless extended by the Company. The Company expects...

Continue reading

Blue Rhino Renews its Partnership with the Steak Cookoff Association

Written by Customer Service on . Posted in Public Companies.

WINSTON-SALEM, N.C., March 06, 2024 (GLOBE NEWSWIRE) — Blue Rhino, the propane tank exchange brand of Ferrellgas Partners, L.P. (OTC: FGPR), is proud to announce it is continuing its sponsorship of the Steak Cookoff Association (SCA) in 2024. The SCA hosted more than 500 competitions in the United States last year, including some events where competitors earned an extra prize by grilling their winning steak using Blue Rhino propane. “When you think of backyard grilling, you think of Blue Rhino,” said Mark Tucker, Blue Rhino’s Vice President of Sales. “The brand is everywhere grilling takes place. That includes the SCA, which features some of the top backyard grillers at their competitions. We love to help people take their grilling to the next level, and we can’t wait to see the dishes everyone comes up with this year.” In addition...

Continue reading

Sprott Launches Copper Miners ETF

Written by Customer Service on . Posted in Public Companies.

Only U.S.-Listed ETF That Provides Pure-Play Exposure to Large, Mid- and Small-Cap Copper Miners Copper Miners ETF Adds to Sprott’s Expanding ETF Suite TORONTO, March 06, 2024 (GLOBE NEWSWIRE) — Sprott Asset Management LP (“Sprott”) today announced the launch of the Sprott Copper Miners ETF (Nasdaq: COPP) (the “ETF” or “COPP”), the only1 U.S.-listed ETF to provide pure-play2 exposure to large, mid- and small-cap copper miners that supply a critical material necessary for the energy transition. The ETF is the most recent addition to Sprott’s suite of critical materials-focused ETFs and is Sprott’s second copper mining fund, joining the Sprott Junior Copper Miners ETF (COPJ), which launched in February 2023. “Global commitments to meet net-zero emissions by 2050 are reliant upon copper-intensive electrification initiatives, such...

Continue reading

Ubiquitech Software Corp. (OTC:UBQU) Announces Strategic Acquisition of Innovative Outcomes, Inc., an Established Leader in the Multi-Billion Dollar Medical Wound Care Segment

Written by Customer Service on . Posted in Mergers And Acquisitions.

DENVER, CO, March 06, 2024 (GLOBE NEWSWIRE) — via NewMediaWire – Ubiquitech Software Corp. (OTC: UBQU) a dynamic and innovative software development company, is pleased to announce its acquisition of Innovative Outcomes, Inc. (Innovative Outcomes), a prominent player in the multi-billion-dollar medical wound care industry currently posting five million dollars per year in revenue. The strategic move is set to further strengthen Innovative Outcomes presence in the healthcare sector and enhance its commitment to providing cutting-edge solutions. Innovative Outcomes has established itself as a leading company specializing in advanced medical wound technologies. The acquisition aligns with Ubiquitech’s vision to expand its portfolio and leverage technology to address critical healthcare challenges. The integration of Innovative Outcomes...

Continue reading

BrainsWay Reports Fourth Quarter and Full-Year 2023 Financial Results and Operational Highlights

Written by Customer Service on . Posted in Public Companies.

Generated Record Revenues with Robust 50% Year-over-Year Revenue Growth in Q4 2023; Generated Positive Quarterly Net Income Providing Full-Year 2024 Revenue Guidance of $37-$40 Million with Continued Profitability Momentum and Cash Generation Conference Call to be Held Today at 8:30 AM ET BURLINGTON, Mass. and JERUSALEM, March 06, 2024 (GLOBE NEWSWIRE) — BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a world leader in advanced and non-invasive treatment for brain disorders, today reported fourth quarter and full-year 2023 financial results and provided an operational update. Recent Financial and Operational HighlightsFor the three months ended December 31, 2023, revenues were $9.0 million, a 50% increase as compared to the fourth quarter of 2022, and a 9% increase over the third quarter of 2023. Gross...

Continue reading

Cognition Therapeutics Presents Analyses at AD/PD™ 2024 Correlating Proteomic Findings with Treatment Effect of CT1812 in Alzheimer’s Disease Studies

Written by Customer Service on . Posted in Public Companies.

PITTSBURGH, March 06, 2024 (GLOBE NEWSWIRE) — Cognition Therapeutics, Inc. (NASDAQ: CGTX), a clinical stage company developing product candidates that treat neurodegenerative disorders, (the “Company” or “Cognition”), is presenting results of proteomic and correlation analyses of two completed clinical studies at the AD/PD™ 2024 Alzheimer’s & Parkinson’s Diseases Conference (March 5-9, 2024 in Lisbon, Portugal). The three posters, which are listed below, summarize proteomic analyses from the completed SEQUEL and SPARC studies, which were conducted in adults with mild-to-moderate Alzheimer’s disease.VIRTUAL Identification of New Pharmacodynamic Biomarkers of CT1812 that Correlate with Favorable Functional Connectivity of the Brain Di Caro V, Pandey K, Cho E, Duong D, de Haan W, Grundman M, Seyfried N,...

Continue reading

Kura Oncology Reports First Patient Dosed in Trial of KO-2806 Plus Cabozantinib in Renal Cell Carcinoma

Written by Customer Service on . Posted in Public Companies.

– Company anticipates dosing of KO-2806 in combination with adagrasib in KRASG12C-mutant NSCLC next quarter – – Dose escalation of KO-2806 as a monotherapy continues in parallel – SAN DIEGO, March 06, 2024 (GLOBE NEWSWIRE) — Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced dosing of the first patient with KO-2806, the Company’s next-generation farnesyl transferase inhibitor (FTI), in combination with the tyrosine kinase inhibitor (TKI) cabozantinib in the clear cell renal cell carcinoma (ccRCC) cohort of the Phase 1 portion of the FIT-001 trial. “Dosing of the first patient in combination in our Phase 1 trial of KO-2806 marks a significant milestone for our next-generation FTI program,” said Stephen...

Continue reading

Ollie’s Bargain Outlet Holdings, Inc. Announces Fourth Quarter and Full-Year Fiscal 2023 Release Date and Conference Call Information

Written by Customer Service on . Posted in Public Companies.

HARRISBURG, Pa., March 06, 2024 (GLOBE NEWSWIRE) — Ollie’s Bargain Outlet Holdings, Inc. (NASDAQ: OLLI) (the “Company”) announced today that it will release its financial results for the fourth quarter and full-year fiscal 2023 on Wednesday, March 20, 2024, before the market opens. Following the release, at 8:30 a.m. Eastern Time, the Company’s management team will host a conference call to discuss its results. To access the live conference call, please pre-register here. Registrants will receive a confirmation with dial-in instructions. Interested parties can also listen to a live webcast or replay of the conference call by logging on to the Investor Relations section on the Company’s website at http://investors.ollies.us/. About Ollie’sWe are America’s largest retailer of Closeout merchandise and excess inventory, offering Real...

Continue reading

23andMe Launches New Genetic Reports on Common Forms of Cancer

Written by Customer Service on . Posted in Public Companies.

23andMe customers can now gain deeper insight into their likelihood of developing breast, colorectal, and prostate cancer through new reports based on polygenic risk scores (PRS) developed by 23andMe SOUTH SAN FRANCISCO, Calif., March 06, 2024 (GLOBE NEWSWIRE) — 23andMe Holding Co. (Nasdaq: ME), a leading human genetics and biopharmaceutical company, released three new genetic reports for 23andMe+ members on breast, colorectal and prostate cancer. The reports are based on statistical models known as polygenic risk scores (PRS), developed by 23andMe through its proprietary research database. These PRS reports calculate the likelihood of an individual developing one of these cancers, based on thousands of genetic variants associated with the disease. Recent studies show a rise in younger people being diagnosed with cancer. A BMJ...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.